Organisation: Enbrel

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

news

Taxpayers and patients lose out over lack of lower cost medicines

Major reform is still needed to pass on savings on medicines to taxpayers and patients.

news

Pharmacists ‘gave double dose of drug’

business

Pfizer profit beats forecast

business

Impact of expiry of global patents ‘less than feared’

business

Pfizer’s profit down 19% as sales hit by generic competition

news

Aspirin scripts on medical card cost €5.1m per year

Irish drug exports at risk as patents expire

SOME €19 billion of Irish pharmaceutical exports may be impacted by the expiration of patents on a number of blockbuster medicines produced here.

Wed, 23 Nov, 2011

Vaccine sales’ rise boost for Wyeth

WYETH’S first-quarter earnings rose 44% as sales of its vaccine against childhood infections more than doubled and sales of arthritis treatment Enbrel and other prescription drugs rose.

Thu, 21 Apr, 2005